Septerna, Inc.

SEPN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.1B · 130 employees
31
SEC Filings
$30.2
Close 2026-05-29
130
Employees

Business Summary

Septerna, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing oral small molecule therapeutics targeting G protein-coupled receptors (GPCRs). The company utilizes its proprietary Native Complex Platform to develop product candidates including SEP-479 and SEP-631. Septerna has a partnership with Novo Nordisk A/S to develop oral small molecule therapies for metabolic-related diseases targeting GLP-1, GIP, and glucagon receptors for obesity, type 2 diabetes, and related conditions.

Latest Stock Quote

SEPN 2026-05-29 $30.2 O:$30.96 H:$31.6 L:$29.71 Vol:0.3M VWAP:$30.2497
origin leaf: e06b045c3b0bb9a66490cfd2dc5c1e94659c45bc018f4068ba35b0f8fce652e6

Next Earnings

Q2 FY2026 — expected 2026-09-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-098507EDGAR122K words
2025-03-272024-12-310000950170-25-045745EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-273375EDGAR33K words
2025-08-112025-06-300000950170-25-106551EDGAR—
2025-05-152025-03-310000950170-25-072619EDGAR—
2024-11-202024-09-300000950170-24-129274EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001193125-26-098489EDGAR2K words
2026-03-020001193125-26-084142EDGAR—
2026-01-120001193125-26-009864EDGAR—
2026-01-080001193125-26-007772EDGAR—
2025-11-100001193125-25-273373EDGAR—
2025-09-290001193125-25-223292EDGAR—
2025-09-030001193125-25-194472EDGAR—
2025-08-210001193125-25-184706EDGAR—
2025-08-110000950170-25-106540EDGAR—
2025-08-040001193125-25-172595EDGAR—

31 total filings indexed. 15 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

obesity type-2-diabetes metabolic-related-diseases

Company Identity

CIK0001984086
TickerSEPN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.septerna.com
Listed2024-10-25

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 3f9dfa88683091e0733173b704661cf2b84066cf6450ba11cc40e90e6c80b81a
parent: 61c3a0dbc84d5f8edfb7cba3c1e9ddc84c3119807423c4e2e8fe48fb4b0f830b
content hash: 0e0e065dcb59bd3f11d0556c1ad22df3847d9bcfe1b55ed66f8918653a09ebbc
signed: 2026-06-02T19:02:35.363Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf